Home/Filings/4/0000899243-22-038909
4//SEC Filing

Brooks Mark W 4

Accession 0000899243-22-038909

CIK 0000319016other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 9:02 PM ET

Size

6.2 KB

Accession

0000899243-22-038909

Insider Transaction Report

Form 4
Period: 2022-12-15
Brooks Mark W
DirectorSee Remarks10% Owner
Transactions
  • Award

    Common Stock

    2022-12-15$0.15/sh+333,333$50,000882,586 total
Footnotes (2)
  • [F1]On December 15, 2022 the Reporting Person was issued 333,333 shares (the "Shares") of the restricted common stock, par value $0.01 per share (the "Common Stock"), of Fuse Medical Inc. (the "Company") pursuant to the Amended and Restated 2018 Equity Incentive Plan of Fuse Medical Inc. (the "2018 Plan") (incorporated by reference to Exhibit 10.1 of the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on December 18, 2018 (File No. 000-100093)), subject to the terms and conditions in the 2018 Plan.
  • [F2](Continued From Footnote I) The Shares will vest and cease to be subject to forfeiture upon (a) the occurrence of one of the following events (each, an "Accelerating Event"): (A) the listing of the Company's Common Stock on either the NYSE or the NASDAQ Stock Market; or (B) a change in Control (as defined in the 2018 Plan); and (ii) the delivery by the Reporting Person to our company of a Notice of Acceleration of Vesting (as defined in award agreement) no later than sixty (60) days following the earlier of (A) the date our Company sends written notice of such Accelerating Event or (B) the date the Reporting Person actually or constructively becomes aware that such Accelerating Event has occurred.

Issuer

Fuse Medical, Inc.

CIK 0000319016

Entity typeother

Related Parties

1
  • filerCIK 0001688048

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:02 PM ET
Size
6.2 KB